A community for people who want to remain as healthy as possible as we age.

Pharma Ties Common on Guideline Panels

(MedPage Today) Three-quarters of the members on guideline panels that proposed changes in disease definitions and diagnostic criteria had ties to drug companies, a study found.
Furthermore, 12 of the 14 panel chairs had financial ties to the pharmaceutical industry, according to the research…
"Companies with financial relationships with the greatest proportion of panel members were marketing or developing drugs for the same conditions about which those members were making critical judgements," Ray Moynihan, of Bond University in Robina, Australia, and colleagues wrote.
[Click the title, above, to post a comment.]


Post a Comment

Please do not give advice. We can best help each other by telling what works for us, not what we think someone else should do.